Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 23;44(9):116113.
doi: 10.1016/j.celrep.2025.116113. Epub 2025 Aug 25.

Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALS

Affiliations
Free article

Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALS

Barbara Szewczyk et al. Cell Rep. .
Free article

Abstract

Mutations in the Fused in Sarcoma (FUS) gene cause familial amyotrophic lateral sclerosis (ALS), characterized by selective degeneration of spinal motor neurons (sMNs) with relative sparing of cortical neurons (CNs). The mechanisms underlying this cell-type vulnerability remain unclear. Here, we compare CNs and sMNs derived from FUS-ALS models to assess differential responses to FUS mutations. We find that CNs are less affected than sMNs in DNA damage repair, axonal organelle trafficking, and stress granule dynamics. RNA sequencing (RNA-seq) reveals distinct transcriptomic signatures, with sMNs uniquely activating DNA damage responses involving cell cycle regulators, particularly polo-like kinase 1 (PLK1). PLK1 is highly expressed in sMNs but not CNs, correlating with greater nuclear FUS loss and splicing defects in sMNs. Cross-comparison with other familial ALS RNA-seq datasets highlights PLK1 upregulation as a shared molecular feature. These findings identify intrinsic differences between CNs and sMNs in FUS-ALS and suggest PLK1 as a potential driver of sMN vulnerability.

Keywords: CP: Molecular biology; CP: Neuroscience; DNA damage response; FUS loss of function; FUS-ALS; PLK1; neurodegeneration; polo-like kinase 1; selective vulnerability; transcriptomics.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests A.H. has received personal fees and non-financial support from Biogen and Desitin during the conduct of the study outside of the submitted work. R.G. has received honoraria from Biogen as an advisory board member and for lectures and as a consultant and advisory board member from Hoffmann-La Roche. He also received travel expenses and research support from Biogen. B.J.W. is a consultant and member of the scientific advisory board of Quralis.

MeSH terms

LinkOut - more resources